Annual Assembly 2016

Annual Assembly

Satellite Symposia

AAPM&R allows third-party sponsored CME activities called Satellite Symposia. The third-party may garner support for their activity from industry. Third-party CME providers are required to follow all guidelines outlined by ACCME.

Cutting Primary and Secondary ACL Injury Risk with Newly-Sharpened Tools

Thursday, October 20, 2016, 7:45 pm-9 pm                                                              
Hilton New Orleans, Grand Salon A 

Cutting Primary and Secondary ACL Injury Risk with Newly Sharpened Tools is a presentation that details the latest primary and secondary ACL prevention programs for athletes. Dr. Hewett will describe state of the art 3D motion analysis used to teach athlete screening techniques and neuromuscular training methods that focus on proper core and knee control and landing techniques. Dr. Hewett will describe laboratory and clinic-based risk screening experience and how they relate to anterior cruciate ligament injury prevention.

Mayo Clinic designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This is an independent activity sponsored by Mayo Clinic.

Strategies for Combating Opioid-Induced Constipation: Targeted Mechanisms to Maintain Pain Control Without Compromise

Friday, October 21, 2016, 5:45 pm-7:30 pm
Hilton New Orleans Riverside, Chart Ballroom

Opioid-induced constipation (OIC) is a common side effect of opioid use and can occur from the outset of opioid therapy. OIC has been reported to interfere with pain management, increase health care costs, decrease work productivity and daily activities, and significantly affect patient quality of life. It can also lead to bowel obstruction. Assessing and managing OIC is important for establishing maximum function for patients. Several pharmacologic approaches, with different mechanisms of action, are available or in development.

Pre-register here. On-site registration may be available, space permitting. Pre-registration does not guarantee seating. Arrive early—seating is limited!

The Elsevier Office of Continuing Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This live educational activity is jointly provided by the Elsevier Office of Continuing Medical Education and Miller Medical Communications, LLC.  This live activity is supported by an independent educational grant from AstraZeneca, Salix Pharmaceuticals, Inc., and Shionogi, Inc.

Spasticity Video Challenge: A Look at Methods for Addressing Difficult Cases

Saturday, October 22, 2016, 5:45 pm-7 pm
Hilton New Orleans Riverside, Chart Ballroom

This live activity is jointly provided by the Elsevier Office of Continuing Medical Education and ASIM. This activity is designated for a maximum of 1.5 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

This activity is supported by an independent educational grant from Allergan, Inc. 

Product Theaters/Product Forums

Product Theaters are 60-minute sessions, which highlight issues such as patient education, specific products, and therapeutic areas. They are held in private rooms. Product Theater presentations are independent and do not offer CME credit.

Product Forums are similar, but 20-minute sessions held in the PM&R Pavilion. Product Forum presentations are independent and do not offer CME credit. 

Adult Focal Spasticity Today

Thursday, October 20, 2016, 1 pm-2 pm
Ernest N. Morial Convention Center, Rooms 208-210

This informative and engaging presentation discusses the latest addition to your treatment armamentarium for adult focal spasticity, with a focus on the lower limbs. It features clinical data and appropriate patient types along with interactive videos and simulations that showcase an effective treatment approach.

Presented by: Allergan

Improving Patient Care During Short-Term Opioid Therapy: Focusing on Opioid-Induced Nausea and Vomiting (OINV)

Thursday, October 20, 2016, 1 pm-2 pm
Speaker: Srinivas Nalamachu, MD
Ernest N. Morial Convention Center, Rooms 211-213

Please join us for a presentation that will provide an in-depth look into one of the most common and burdensome side effects of short-term opioid therapy and review ways to improve care for patients who receive opioids for acute pain management. 

Presented by: Diiachi logo-black and white

Closing the Gap on Research vs. Reality

Friday, October 21, 2016, 12:45 pm-1:45 pm
Speaker: Cindy B. Ivanhoe, MD, Attending Physician, Brain Injury and Stroke Program TIRR Memorial Hermann
Ernest N. Morial Convention Center, Rooms 211-213

A look at the complex spasticity patient and achievement of realistic treatment goals with Xeomin® (incobotulinumtoxinA)

Presented By: Merz_NA_Pantone

Pseudobulbar Affect: A Commonly-Missed Complication of Neurologic Disorders Patient Identification, Diagnosis, and Treatment

Friday, October 21, 2016, 12:45 pm-1:45 pm
Speaker: Jason P. Caplan, MD
Ernest N. Morial Convention Center, Rooms 208-210

Please join us for a clinical discussion about pseudobulbar affect (PBA), a condition that occurs secondary to a variety of otherwise unrelated neurologic conditions or brain injury, and is characterized by episodes of uncontrollable crying and/or laughing. An estimated 7 million people with neurologic conditions or brain injuries have symptoms suggestive of PBA; however, PBA is often underdiagnosed or may be mischaracterized as depression or symptoms associated with the patient’s underlying neurologic condition. In this program, you will hear from an expert about how PBA presents, how to undercover and diagnose it in your patients, as well as about a safe and effective treatment option for this condition.

Presented by: OAPI_ color

 

Everything You Want to Know About Bone Marrow Concentrate But Are Afraid to Ask

Friday, October 21​, 2016, 2 pm-2:20 pm
Speaker: Ted Sand, PhD
PM&R Pavilion, Booth 1215

Celling Biosciences presents the ART BMC+, which processes the concentration of autologous bone marrow aspirate at point-of-care, and it features an integrated ultrafiltration system for the concentration of plasma. Dr. Sand will discuss essential features of concentrated bone marrow aspirate for achieving beneficial therapeutic outcomes, and he will present data from published literature on clinical indications for bone marrow concentrate, like rotator cuff repair, degenerative disc disease, and osteoarthritis.

Presented by:   CELLING LOGO VECTOR - ORANGE and BLACK

Strengthening Your Pain Management Arsenal

Saturday, October 22, 2016, 12:45 pm-1:45 pm
Ernest N. Morial Convention Center, Rooms 208-210

 

Presented by: Egalet_Logo_CMYK_fullcolor

A New FDA-Approved Treatment for Pediatric Patients with Lower Limb Spasticity (ages 2 and older)

Saturday, October 22, 2016, 12:45 pm-1:45 pm
Speaker: Mark E. Gormley Jr., MD and Christina Kwasnica, MD
Ernest N. Morial Convention Center, Rooms 211-213

This interactive product theater will feature a clinical presentation and a hands-on practical workshop for a prescription injectable treatment for lower limb spasticity in pediatric patients ages 2 and older. The presentation will review an FDA-approved botulinum toxin for the treatment of pediatric lower limb spasticity for ages 2 and older. Following the presentation, a well-known, experienced injector will provide a live demonstration on how to administer this injectable therapy. Product theater attendees will have an opportunity to participate in a hands-on workshop, practicing injections on synthetic human tissue models.

Presented by:     Ipsen_Logo_4C